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Abstract
Background: Adenoviruses are attractive vectors for gene therapy because of their stability in vivo and the possibility of
production at high titers. Despite exciting preclinical data with various approaches, there are only a few examples of clear
efficacy in clinical trials. Effective gene delivery to target cells remains the key variable determining efficacy and thus
enhanced transduction methods are important.
Methods/Results: We found that heated serum could enhance adenovirus 5 mediated gene delivery up to twentyfold. A
new protein-level interaction was found between fiber knob and serum transthyretin, but this was not responsible for the
observed effect. Instead, we found that heating caused the calcium and phosphate present in the serum mix to precipitate,
and this was responsible for enhanced gene delivery. This finding could have relevance for designing preclinical
experiments with adenoviruses, since calcium and phosphate are present in many solutions. To translate this into an
approach potentially testable in patients, we used calcium gluconate in phosphate buffered saline, both of which are
clinically approved, to increase adenoviral gene transfer up to 300-fold in vitro. Gene transfer was increased with or without
heating and in a manner independent from the coxsackie-adenovirus receptor. In vivo, in mouse studies, gene delivery was
increased 2-, 110-, 12- and 13-fold to tumors, lungs, heart and liver and did not result in increased pro-inflammatory
cytokine induction. Antitumor efficacy of a replication competent virus was also increased significantly.
Conclusion: In summary, adenoviral gene transfer and antitumor efficacy can be enhanced by calcium gluconate in
phosphate buffered saline.
Citation: Ahonen MT, Diaconu I, Pesonen S, Kanerva A, Baumann M, et al. (2010) Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with
Adenovirus Type 5. PLoS ONE 5(9): e13103. doi:10.1371/journal.pone.0013103
Editor: Paul Cobine, Auburn University, United States of America
Received May 4, 2010; Accepted September 9, 2010; Published September 30, 2010
Copyright:  2010 Ahonen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Helsinki Biomedical Graduate School, Suomen hammaslaakariliitto Apollonia, the European Research Council, EU FP6
APOTHERAPY and THERADPOX, Helsinki University Central Hospital (HUCH) Research Funds (EVO), the Finnish Cancer Society, the Sigrid Juselius Foundation, the
Academy of Finland, Biocentrum Helsinki, and the University of Helsinki. AH is K. Albin Johansson Research Professor of the Finnish Cancer Institute. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vincenzo.cerullo@helsinki.fi (VC); akseli.hemminki@helsinki.fi (AH)
. These authors contributed equally to this work.
Introduction
The success of gene therapy is dependent on the use of an
efficient gene transfer system to allow the expression of the
therapeutic gene in the target organ, tissue or cell. Adenoviruses
are one of the most popular vectors because of their stability in
vivo and the possibility of production of high titers [1–3]. Despite
exciting preclinical data with various delivery methods, there are
only few examples of clear efficacy in clinical trials and all of these
trials have employed local delivery [4–9].
In contrast, systemic administration of high doses of adenovi-
ruses can result in toxicity characterized by a pro-inflammatory
cytokine storm, intravascular disseminated coagulopathy and
organ failure [10,11]. Hence, identification of new approaches
that can increase gene delivery without enhanced toxicity remains
important.
Classically, the cellular entry of the most common adenovirus
gene therapy vector, serotype 5 (Ad5), initiates by binding of the
fiber knob to the primary receptor, the coxsackie-adenovirus
receptor (CAR) [12]. This interaction has been suggested to be an
important rate-limiting step for gene transfer, i.e., lack of CAR could
make target tissues refractory. [13–16]. It has been also shown that
certain blood factors can interact with adenovirus [17,18].
In one of our previous studies, we anecdotally discovered that
heated mouse serum can enhance adenoviral gene delivery to
cancer cells in vitro [19]. In this manuscript, we sought to confirm
the finding in clinically meaningful substrates and then unravel the
mechanism behind it. Finally, we applied the mechanism for
enhancing adenoviral gene transfer to tumor tissue and normal
organs. Interestingly, we discovered that calcium and phosphate
were responsible for the phenomenon. Therefore, our findings
extend a classic in vitro technique [20] into in vivo benefits.
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Materials and Methods
Ethics statement
All animal experiments were approved by the Experimental
Animal Committee of the University of Helsinki and the
Provincial Government of Southern Finland (ESLH-2008-01986).
Cell lines and viruses
Cancer cell lines used in this study included human breast cancer
cell line M4A4-LM, [21], chinese hamster ovary cell lines CHO
(with or without human CAR transgene) [22] . Lung adenocarci-
noma cells A549 were bought from ATCC (Manassas, VA USA).
All cell lines were maintained in the recommended conditions.
Replication deficient adenovirus: Ad5(gl) encoding luciferase
and green fluorescent protein and were propagated on 293 cells
and purified on cesium chloride gradients as described [23]. The
viral particle (VP) concentration was determined at 260 nm, and
standard plaque assay on 293 cells was performed to determine
infectious particles.
Ad300wt is a replication competent wild type adenovirus 5
acquired from ATCC.
In vitro gene transfer assay
Different concentrations of mouse serum (Sera Laboratories
International, United Kingdom), vitamin B mixture (Orion
Pharma, Finland), purified vitamin Bs (Sigma Aldrich), Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma Aldrich), calcium
chloride (CaCl2) (Sigma Aldrich), EDTA (Sigma Aldrich) or
calcium gluconate (CaGl) (B Braun, Germany) were mixed with
phosphate buffer solution (PBS). Mixtures were heated to 80uC for
30 min and cooled down to room temperature (RT). Mixtures
were vortexed and supernatant was collected. The pH was
adjusted to 7.4 with 1M NaOH. Viruses at 100vp/cell were added
to the mixtures and incubated for 30 min at room temperature.
Cell lines seeded in 24 well plates in quadruplicates at 16104
cells/well were incubated with Ad5(gl) in the mixtures described
above for 30min. Infection media was replaced with fresh growth
media containing 10% FCS and cell monolayers were incubated
for 48h . Cell lysates were analyzed using luciferase assay (E1500,
Promega, WI, USA).
A549 cell line monolayers were infected with either Ad5(gl) and
CaGl or Ad5(gl) alone for 30minutes. Infection media was
replaced and plates were visualized for GFP expression 24 hours
post infection.Pictures were taken at 106magnification with an
axiovert 200 microscope.
In vitro replication assay
Calcium gluconate mixtures were prepared as described for in
vitro gene transfer assay. Replicating Ad300wt at 10VP/cell was
added to the mixtures and incubated for 30 min at room
temperature. A459 cells were seeded in 12 well plates in
quadruplicates at 156104 cells/well were incubated with virus in
mixtures described above for 30 min. Infection media was
replaced with fresh growth media containing 10% FCS and cell
monolayers were incubated for 2h, 6h, 18h, 30h, 42h, 54 or 66h.
Cell lysates were analyzed using quantitative PCR (Lightcycler,
Roche, Mannheim, Germany) as described [24].
Mass spectrometry (MS) analysis
Recombinant Ad5 knob proteins were bound to magnetic beads
(Qiagen, Germany). Heated or unheated serum was added and the
mixture was incubated for 2h at 4uC. The complexes were washed
with ice-cold PBS five times. Knob-interacting proteins were
eluted with 8M urea. The denaturated proteins were run on a
10% SDS-PAGE gel, silver stained (GE healthcare, United
Kingdom), concentrated with ZipTip RP C-18 (Millipore,
Bedford, MA, USA) and further analyzed by a Bruker Daltonics
(Bremen, Germany) Autoflex III mass spectrometer operated in
the linear positive ion mode (large proteins) or the reflector mode
(smaller peptides) [25].
Fluorescence-activated cell sorting array
Mouse interleukin 6 (IL-6), IL 12p70 and TNF-a were analyzed
with a BD cytokine multiplex bead array system (BD FACSArray;
BD Biosciences, San Jose, CA).
Animal experiments
Immune-competent ICR mice (Taconic, Ejby, Denmark) were
quarantined for 2 weeks. Mice were housed in plastic cages with
wire mesh covers in a room with a 12-h light–dark cycle with
50610% relative humidity at 2461uC. In the intravenous
experiment, c57bl mice were injected with 16109 VP or 161010
VP Ad5(gl) (low or high dose group) mixed with CaGl (4.5mg/ml).
After 6h, serum was collected for cytokine analysis. After 48h mice
were killed and organs were collected and stored at280uC. Organs
were homogenized and lysed with Cell Culture Lysis Buffer
(Promega Corporation, Madison, WI, USA, Nr. E153A), freeze-
thawed three times, and supernatants were analyzed with FluoStar
Optima luminometer. Results were normalized to protein content
by DC Protein Assay (Bio-Rad, Hercules, Manassas, CA, USA).
In the intratumoral experiment, nude mice were injected
orthotopically into the left and right uppermost mammary fat pad
with 26106 M4A4-LM3 cells and a tumor was allowed to develop
[21]. When tumors reached approximately 0.5 cm, mice were
randomized into groups and injected with 16107 VP/tumor of
Ad5(gl) with CaGl (1.2mg/ml) or with PBS (n = 8 tumors/group).
Viruses were injected intratumorally in a total volume of 50 ml.
After 24h mice were killed and tumors were collected and stored at
280uC. Tumors were homogenized, lysed, analyzed and normal-
ized as described above.
For the anti-tumor efficacy experiment, tumors were grown in
nude mice as above. When tumors reached approximately 0.5cm,
mice were randomized into groups and injected with 16107 VP/
tumor of replicating Ad300wt with heated CaGl (1.2mg/ml) or
with PBS (n = 8 tumors/group). Viruses were injected intratumo-
rally in a total volume of 50ı`l. Size of the tumors were measured
every other day.
In vivo imaging
4.5 mg of D-Luciferin (Promega, Madison, WI, USA) in 100 ml
0% Roswell Park Memorial Institute (RPMI) growth medium was
injected intraperitoneally. After 10 min, images were captured
with the IVIS imaging system series 100 using Living Image v2.5
software (Xenogen, Alameda, CA, USA) and photon emission
values were calculated.
Statistical analyses
To compare differences between groups, two-tailed student’s t-
test was used and a P-value of ,0.05 was considered significant.
Results
Gene delivery with adenovirus 5 (Ad5) is increased in the
presence of heated serum
In an earlier study [19] we found that serum from non-
immunized mice heated to 65uC (to inactivate complement)
increased transgene expression in vitro. To confirm this finding we
CaGl and Transgene Expression
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analyzed transgene expression of Ad5(gl) with serial dilutions of
heated serum on UT-SCC29 (not shown) and A549 cells (Fig. 1a).
We observed up to 20 fold increased transgene expression in cells
infected with mixture of Ad5 with the highest concentration of
serum compared to cells infected with virus diluted in PBS.
To further characterize the observation we performed a series of
experiments where cells were infected with a mixture of Ad5 and
heat-inactivated serum at different temperatures. We observed
that when serum was subjected to 56uC for 30min (another
commonly used protocol to heat-inactivate complement) transgene
expression was not affected but when heated to 80uC a significant
increased in transgene expression was seen (Fig. 1b). Further, we
analyzed different lengths of incubation of virus mixed with serum.
At both 30min and 48h we noticed a significant increase of
transgene expression when compared with virus only (Fig. 1c).
To assess whether this observation was translatable into more
clinically relevant in vivo results, mice bearing subcutaneous tumors
were injected intratumorally either with virus or with virus mixed
with heated serum. Significantly higher transgene expression was
observed in the group of mice treated with Ad5(gl) mixed with
heated serum (Fig. 1d). In conclusion, we found that heated serum
can enhance gene delivery of adenovirus in vitro and in vivo.
Mouse transthyretin (TTR) binds to Ad5 knob
We hypothesized that the factor interacting with Ad5 and
mediating enhanced delivery would be a protein. Therefore,
heated and unheated mouse serum was precipitated with Ad5 fiber
knob domains and analyzed by tandem mass spectrometry. A
protein of the size of 15kDA was identified in the fraction
corresponding to heated serum incubated with fiber knob; such a
protein was not present in the fraction corresponding to un-heated
serum preincubated with fiber knob (Fig. 2a). The identified
protein was analyzed by mass spectrometry and identified as
monomeric mouse transthyretin (TTR). TTR is a tetrameric
protein composed of identical subunits having a predominantly b-
sheet structure [26]. TTR is found in serum and cerebrospinal
fluid of mammals and it functions as a secondary carrier for
thyroid hormone thyroxin and for retinol-binding protein [27]. It
Figure 1. Heated mouse serum increases transgene expression of Ad5(gl) in vitro and in vivo. a) A549 cells were infected with replication-
deficient luciferase expressing Ad5(gl) at a concentration of 100VP/cell with or without heated mouse serum. b) Different heating temperatures of
mouse serum (56uC for 1h and 80uC for 30min) and c) different infection periods (30 minutes and 48 hours (h) with or without heated mouse serum.
d) Nude mice with M4A4-LM3 mammary fat pad tumors were injected intratumorally with a Ad5(gl) at a dose of 16107 VP/tumor (n = 4 mice/group).
Tumors were collected 48h following injection, lyzed for luciferase assay and normalized to protein content. Luciferase activity was measured as
relative light units (RLU) 48 hours after infection. *,P,0.05; **,P,0.01 and ***,P,0.001.
doi:10.1371/journal.pone.0013103.g001
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is a heat-resistant protein that only partially denaturates after
heating and almost completely regains its normal form after re-
cooling [28].
After establishing the interaction of Ad5 with TTR, we
investigated whether this was responsible for enhanced transduc-
tion. A549 cells infected with or without purified mouse TTR
resulted in no change in gene delivery (Fig. 2c). We concluded that
even though there is a physical interaction between the knob
domain of the adenovirus 5 fiber knob and TTR, this interaction
does not influence adenovirus cell entry.
D-Pantothenic acid hemicalcium salt (vitamin B5)
contained in cell growth media increases Ad5 gene
delivery
Because TTR was the only candidate protein identified in mass
spectrometry, we hypothesized next that the causative molecule
would not be a protein. Moreover, we performed experiments to
clarify if the putative gene transfer increasing agent was present in
the serum of mice or the growth medium used as a diluent in all
experiments. Up to 60 times increased transgene expression was
seen with heated growth media compared to virus only (Fig. 3a).
As heated serum alone had no major influence on transgene
delivery, we concluded that the effect had been in fact mediated by
the growth medium used as diluent.
One of the main constituents of growth media are B vitamins.
Thus, we analyzed Ad5(gl) transgene delivery with serial dilutions
of heated and unheated vitamin B mixture. Up to 140 and 20
times (heated and unheated vitamin B mixture) increased
transgene expression was seen (Fig. 3b). When we tested the
different B vitamins individually, only vitamin B5 increased
transgene expression (Fig. 3c and d).
Vitamin B5 is conjugated with calcium which dissolves when
mixed to any solvent [29]. The solvent used in these experiments
was PBS. Interestingly, it is well known that calcium and
phosphate form calcium phosphate (CaPi) precipitates which can
increase transgene expression of adenoviruses [30–36]. EDTA is a
chelating agent that can bind to calcium and block it. When we
combined heated vitamin B5 in PBS with EDTA, the increase in
transgene expression was ablated in a dose dependent manner
(Fig. 3e). Also, an absence of increase in transgene expression was
seen when mixing vitamin B5 to saline solution (0.9% NaCl) which
does not contain any phosphate (Fig. 3f) suggesting that the effect
required both calcium and phosphate. As suggested previously
[30], the effect may be mediated through CaPi precipitates, since
we visually detected precipitates in the test tube and more
precipitates were seen when heating was applied.
Calcium gluconate (CaGl) enhances adenovirus
transduction in vitro
CaPi precipitates have been reported to increase transgene
expression of adenovirus in vitro as well as in vivo [30,33,35].
However, there is no clinically approved approach allowing
human use of this information. Therefore, we tested if calcium
gluconate (CaGl) could be combined with PBS for results similar
to what were seen with serum and vitamin B5. CaGl increased
gene delivery up to 75-fold when combined to PBS but not when
combined to NaCl (Fig. 4a). CaGl is globally approved for
treatment of hypocalcaemia [37,38] while PBS is also widely used
in humans; typically when an isotonic and non-toxic solution is
needed [39–41]. To assess dose response, we analyzed serial
dilutions of heated CaGl and found that intermediate doses gave
the best results (Fig. 4b). Importantly, also unheated CaGl
increased gene delivery up to 20 fold (Fig. 4c) CaGl with Ad5(gl),
which might perhaps facilitate clinical testing.
To investigate if the effect was CAR related, we studied CHO
cells which do not express endogenous CAR. As a control we used
CAR transfected CHO cells which stably express CAR [22]. The
former are known to be resistant to adenovirus, as confirmed here
(Fig. 4d), whereas the latter are susceptible (Fig. 4e). While CaGl
increased gene delivery in both cell lines, the effect was more
Figure 2. Identification of Ad5 knob binding proteins in heated
mouse serum. a) Silver stained gel showing molecular-weight marker
and proteins probed with Ad5 knob from heated and unheated mouse
serum. b) Mass spectrometry analysis of 15kDa protein probed from
heated mouse serum identified mouse transthyretin (TTR) as an Ad5
knob binding protein. c) Lung adenocarcinoma A549 cells infected with
replication-deficient luciferase expressing Ad5(gl) at a concentration of
100VP/cell with or without different concentrations of heated
recombinant TTR or heated mouse serum. TTR did not increase gene
transfer. Luciferase activity was measured as relative light units (RLU)
48 hours after infection. **,P,0.01.
doi:10.1371/journal.pone.0013103.g002
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Figure 3. Heated D-Pantothenic acid hemicalcium salt (vitamin B5), present in cell growth media, increases transgene expression of
Ad5(gl) in vitro. A549 cells infected with replication-deficient luciferase expressing Ad5(gl) at a concentration of 100VP/cell with or without a) dilutions of
heated growth media, b) heated and unheated dilutions of vitamin B mixture, c) heated vitamin B’s (4mg/ml of folic acid, 4mg/ml of vitamin B1, 0.4mg/ml of
vitamin B2, 4mg/ml of vitamin B3, 4mg/ml of vitamin B5, 4mg/ml of vitamin B6 and 7.2mg/ml of vitamin B8), d) different concentrations of heated vitamin B5,
e) 25mg/ml of heated vitamin B5 with different concentrations of calcium-chelating ethylenediaminetetraacetic acid (EDTA) indicate calcium as the relevant
component in vitamin B5. f) 25mg/ml of heated vitamin B5 in PBS or in physiological saline solution (0.9% NaCl) demonstrate the requirement for
phosphate for enhanced gene delivery. Luciferase activity was measured as relative light units (RLU) 48 hours after infection. **,P,0.01 and ***,P,0.001.
doi:10.1371/journal.pone.0013103.g003
CaGl and Transgene Expression
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Figure 4. Calcium gluconate (CaGl) increases transgene expression of Ad5(gl) in vitro. a) Lung adenocarcinoma A549 cells infected with
replication-deficient luciferase expressing Ad5(gl) at a concentration of 100VP/cell with different concentrations of calcium chloride (CaCl2) mixed to
PBS or 3.1mg/ml of CaCl2 mixed to physiological saline (0.9% NaCl). b) A549 Cells infected with Ad5(gl) at 100VP/cell with different dilutions of heated
or c) unheated CaGl. CAR negative Chinese hamster ovary (CHO) cells and CHO cells expressing human CAR were infected with Ad5(gl) at a
concentration of 100VP/cell with or without CaGl, demonstrating that the effect was not CAR-dependent d) CAR negative CHO cells and e) CHO with
transgenic CAR. Luciferase activity was measured as relative light units (RLU) 48 hours after infection.*,P,0.05; **,P,0.01 and ***,P,0.001.
doi:10.1371/journal.pone.0013103.g004
CaGl and Transgene Expression
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Figure 5. CaGl enhances adenoviral gene delivery to tumors, liver, lung and heart and increases anti-tumor efficacy without an
increase in pro-inflammatory cytokines in vivo. a) Photon emission at 24 h from mice injected intravenously with replication-deficient luciferase
expressing Ad5(gl) at a dose of 56109 VP/mouse with or without 4.5mg of calcium gluconate (CaGl) (n= 4 mice per group). Increased liver transduction
is seen in whole body imaging. Organs were collected frommice were injected intravenously with Ad5(gl) at a dose of b) 16109 VP/mouse and c) 161010
VP/mouse (n= 4 mice per group) with or without 4.5mg of heated CaGl. An increase in gene transfer was seen in lungs, liver and heart. d) 6 h after virus
injection, mouse serum was analyzed for mouse interleukin 6 (IL-6), IL 12p70 and TNF- a. No increase in these adenoviral toxicity markers was seen. e)
Nude mice with M4A4-LM3 mammary fat pad tumors were injected intratumorally with Ad5(gl) at a dose of 16107 VP/tumor (n= 4 mice/group). with or
CaGl and Transgene Expression
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e13103
dramatic in cells lacking CAR (Fig. 4d). This suggested that the
calcium-phosphate mediated effect was independent of CAR.
CaGl enhances adenovirus transduction in vivo
Significantly higher transgene expression, as detected by in vivo
imaging, was observed 24h after virus injection in the group of
mice treated with Ad5(gl) with CaGl (2.860.5 versus 1.360.26105
photons/s, Fig. 5a). The same result was seen when organs were
analyzed ex vivo at 48 hours (Fig. 5b–c).
Increases in gene transfer would be most useful if not
accompanied by increases in toxicity. Therefore, serum cytokines
were measured 6h after virus injection. Interestingly, our analysis
showed that there was no increase in proinflammatory cytokines in
the combination with CaGl (Fig. 5d).
With regard to cancer treatment, adenovirus is most often
delivered intratumorally and this was therefore employed here.
Significantly higher transgene expression was observed 24h after
injection CaGl with virus when compared to virus only (Fig. 5e).
Unheated CaGl was as effective as heated CaGl. CaGl also
resulted in significant anti-tumor efficacy when combined with a
replication competent virus (Fig. 5f). To summarize the in vivo
CaGl experiments, we observed that CaGl treatment enhances
adenovirus transduction to both normal organs and tumors
without increasing proinflammatory cytokine production.
CaGl increases the number of cells transduced but not
does not affect virus replication
To investigate if increased transgene expression resulted from a
larger number of cells transduced or enhanced transgene expression
from the same amount of cells, infection with Ad5(gl) was performed
and GFP positive cells were imaged (Fig. 6a). A higher proportion of
cells were found GFP positive when CaGl was used.
To assess if CaGl impacted post-transduction steps, cells were
infected with a wild type adenovirus with or without CaGl (Fig. 6b).
The virus replicated effectively regardless of CaGl which therefore
affected only transduction and did not compromise post-entry steps.
Discussion
Adenovirus-mediated gene therapy holds potential for many
diseases, but especially for applications requiring high levels of
target tissue transduction. While significant advances in clinical
adenoviral gene therapy applications have been made in especially
cancer treatment, the clinical translation of adenoviral gene
replacement therapy for other diseases has lagged behind. The
field remains restrained by innate immune responses inherent to
adenovirus, which decreases the therapeutic index of systemic
administration of adenovirus particles. Specifically, the efficacy to
toxicity ratio of current approaches has not been sufficient to lead
to clinical successes heretofore. Thus, development of vector and
pharmacologic manipulations, such as suggested here, might
contribute to minimizing vector toxicity while maximizing the
efficacy of systemic and local adenovirus gene transfer.
Previously it has been shown by Shayakhmetov et al that
adenovirus knob can be used to precipitate interacting serum
factors and that they are numerous [18]. Many proteins are
denaturated by heating but serum is known to have some heat
resistant proteins which acquire their native or pseudo-native form
after heating [28]. Here we show a previously undescribed
interaction between Ad5 knob and mouse serum component
transthyretin (TTR). However, TTR did not increase transgene
expression. In its naı¨ve form TTR is present in serum as a
tetramer. When denatured by high temperature, the monomer
had high affinity for adenovirus knob. We believe this finding may
have relevance in the context of several diseases i.e. senile systemic
amyloidosis, familial amyloid polyneuropathy and familial amyloid
cardiomyopathy, where high levels of monomeric TTR are
present [42–44]. It might be worthwhile to study if Ad5 could
be used for effective transduction of tissues with high monomeric
TTR. Also there is some evidence that ischemic areas of the brain
may feature expression of monomeric TTR [45]. This might have
relevance for adenovirus biodistribution in treatment of brain
diseases such as stroke or glioma.
Since serum proteins precipitating with Ad5 knob did not yield
an answer to increased transgene expression we sought to
investigate if heating altered other components of the serum/
virus mix, including the growth media used for dilution of the
serum for normalization of volume. Growth media is a fairly
simple solution consisting only of minerals, amino acids and B
vitamins. Increased transgene expression was seen with vitamin B
mixture and specifically D-Pantothenic acid hemi calcium salt
(Vitamin B5), with or without heating. Interestingly, vitamin B5
was also the only tested vitamin that conjugates with soluble
calcium. Ethylenediaminetetraacetic acid (EDTA) is known for its
ability to chelate metal ions such as calcium [46]. When EDTA
was added, the effect of vitamin B5 was ablated (Fig. 3e).
The solvent used in these experiments was PBS. When vitamin
B5 was diluted to saline solution that does not contain any
phosphate, no increase in transgene delivery was seen (Fig. 3f).
These data suggest that calcium and phosphate are necessary for
the increased transgene expression seen. Therefore, our initial
findings with heated serum led to the well established phenom-
enon of enhancement of adenovirus transduction with calcium
phosphate [30–36].
Our results are in accord with previous studies showing that the
effect is CAR independent [30,36]. However, the calcium
phosphate technique widely used in the laboratory cannot be
applied to humans. Therefore, we sought to extend the approach
to calcium and phosphate substrates accepted for human use:
CaGl and PBS [37–41].
In vitro results with CaGl showed up to 300 times increased
transgene expression, improved even over vitamin B5 (140 times
fold increase). Transgene delivery was increased both with heated
and unheated CaGl (Fig. 4b–c) but a stronger effect was seen after
heating. Following intravenous injection of CaGl with Ad5 we
were able to enhance transduction of many organs (lungs 108,
heart 12 and liver 13 fold compared to Ad5 alone, Fig. 5c). No
significant increases in cytokine levels were observed (Fig. 5d). This
fits well with our current understanding of adenoviral toxicity,
whose main determinant might be the adenoviral particles per se
being recognized by the innate immune system [11,47–49], while
the level of transgene expression may play a smaller role.
Alternatively, CaGl+PBS may enhance the transduction of only
selected cell populations in organs. For example, in the context of
the liver, transduction of hepatocytes might be increased while that
of Kupffer cells not. Hepatocytes express transgenes following
adenoviral transduction, but Kupffer cells do not [50]. Although
cytokines have been proposed as a sensitive marked of adenoviral
without 1.2mg/mg CaGl. Both heated and unheated CaGl increased gene delivery. f) Nude mice with M4A4-LM3mammary fat pad tumors were injected
intratumorally with replication competent (and therefore lytic) wild type adenovirus type 5 at a dose of 16107 VP/tumor (n= 5 mice/group). with or
without heated CaGl (1.2mg/ml) and followed tumor growth for 20 days. *,P,0.05; **,P,0.01 and ***,P,0.001.
doi:10.1371/journal.pone.0013103.g005
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toxicity [51], it is clear that further studied are needed in this
regard. However, it may also be possible the utilization of CaGl
could reduce toxicity of an adenoviral treatment if it allows lower
virus doses to be used.
As a preliminary disease specific application of the findings, we
combined CaGl+PBS with virus for evaluation of the effect on
tumor transduction and improved gene delivery was seen and this
led also to enhance anti-tumor efficacy when applied in the
context of a replication competent adenovirus (Fig. 5e–f). Further
toxicity and efficacy studies are needed in other disease specific
models. Adenovirus vectors have great potential for the treatment
of both hereditary and acquired diseases [52–55] and many
clinical gene therapy applications require expression of therapeutic
transgene at a high level.
In summary, we report that CaGl in PBS can enhance
adenoviral gene delivery to several normal organs and also
tumors. These findings might have relevance for improving the
efficacy versus toxicity ratio of adenoviral gene therapy. Also,
awareness of this phenomenon could be important in designing
preclinical experiments with adenoviruses, since calcium and
phosphate are present in many solutions and might cause
misinterpretation of data.
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